Effects of 25-hydroxyvitamin D3 on cathelicidin production and antibacterial function of human oral keratinocytes

Cellular Immunology

Volumn 283, Issue 1-2, 2013, Pages 45-50

  Wang, Qi ^a,b   Zhang, Wu ^b   Li, Hao ^a   Aprecio, Raydolf ^b   Wu, Wan ^c   Lin, Yiqiao ^b   Li, Yiming ^b  

^a SICHUAN UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

1 Hydroxylase (CYP27B1); 24 Hydroxylase (CYP24A1); 25 Hydroxyvitamin D3; Cathelicidin; Oral keratinocytes

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN 2; CALCIFEDIOL; CATHELICIDIN; CYCLIC AMP; MESSENGER RNA; OXYGENASE; SMALL INTERFERING RNA; VITAMIN D; VITAMIN RECEPTOR;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CAPNOCYTOPHAGA GINGIVALIS; CELL LINE; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; FUSOBACTERIUM NUCLEATUM; GENE SILENCING; HUMAN; KERATINOCYTE; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; STREPTOCOCCUS MUTANS; WESTERN BLOTTING;

1Α-HYDROXYLASE (CYP27B1); 24-HYDROXYLASE (CYP24A1); 25-HYDROXYVITAMIN D(3); CATHELICIDIN; ORAL KERATINOCYTES;

ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CALCIFEDIOL; CELL LINE; GENE KNOCKDOWN TECHNIQUES; HUMANS; KERATINOCYTES; MOUTH MUCOSA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STEROID HYDROXYLASES; TRANSFECTION;

EID: 84880342915     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.06.007     Document Type: Article

References (36)

1. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 2010, 39:365-379.
2. Bikle D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens. 2008, 17:348-352.
3. Ji S., Hyun J., Park E., Lee B.L., Kim K.K., Choi Y. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J. Periodontal Res. 2007, 42:410-419.
4. Zasloff M. Fighting infections with vitamin D. Nature 2011, 12:388-390.
5. McMahon L., Schwartz K., Yilmaz O., Brown E., Ryan L.K., Diamond G. Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect. Immun. 2011, 79:2250-2256.
6. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179:2060-2063.
7. Puklo M., Guentsch A., Hiemstra P., Eick S., Potempa J. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol. Immunol. 2008, 23:328-335.
8. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br. J. Nutr. 2003, 89:552-572.
9. Tashiro K., Ishii C., Ryoji M. Role of distal upstream sequence in vitamin D-induced expression of human CYP24 gene. Biochem. Biophys. Res. Commun. 2007, 358:259-265.
10. Baker A.R., McDonnell D.P., Hughes M. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 1988, 85:3294-3298.
11. Juttmann J., Birkenhager-Frenkel D., Visser T., van Krimpen C., Birkenhager J. Follow-up of long-term treatment of predialysis renal bone disease with 1-[alpha]-hydroxy-derivatives of vitamin D. J. Steroid Biochem. 1983, 19:511-516.
12. Hansdottir S., Monick M.M., Hinde S.L., Lovan N., Look D.C., Hunninghake G.W. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J. Immunol. 2008, 181:7090-7099.
13. Schauber J., Dorschner R.A., Coda A.B. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117:803-811.
14. Ogunkolade B., Boucher B., Fairclough P. Expression of 25-hydroxyvitamin D-1-[alpha]-hydroxylase mRNA in individuals with colorectal cancer. Lancet 2002, 359:1831-1832.
15. Kemmis C.M., Salvador S.M., Smith K.M., Welsh J.E. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J. Nutr. 2006, 136:887-892.
16. 3. J. Cyst. Fibros. 2007, 6:403-410.
17. 3. Cancer Epidemol. Biomar. 1998, 7:391-395.
18. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 1983, 72:1856.
19. INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 2000, 20:1436-1447.
20. Amano Y., Komiyama K., Makishima M. Vitamin D and periodontal disease. J. Oral Sci. 2009, 51:11-20.
21. Feucht E., DeSanti C., Weinberg A. Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol. Immunol. 2003, 18:359-363.
22. Masuda S., Kaufmann M., Byford V. Insights into vitamin D metabolism using cyp24 over-expression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS). J. Steroid Biochem. Mol. Biol. 2004, 89:149-153.
23. Horst R., Reinhardt T., Feldman D. Vitamin D metabolism. Vitamin D 1997, 13-31.
24. Ramos-Lopez E., Bruck P., Jansen T., Pfeilschifter J.M., Radeke H.H., Badenhoop K. CYP2R1-, CYP27B1-and CYP24-mRNA expression in German type 1 diabetes patients. J. Steroid Biochem. Mol. Biol. 2007, 103:807-810.
25. Binkley N., Novotny R., Krueger D. Low vitamin D status despite abundant sun exposure. J. Clin. Endocrinol. Metab. 2007, 92:2130-2135.
26. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
27. Greene-Finestone L., Berger C., de Groh M. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos. Int. 2010, 1-11.
28. Farhan H., Wähälä K., Cross H.S. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. J. Steroid Biochem. Mol. Biol. 2003, 84:423-429.
29. Gambhir V., Kim J., Siddiqui S., Taylor M., Byford V., Petrof E.O., Jones G., Basta S. Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement. Immunobiology 2011, 216:988-996.
30. Khoo A.L., Chai L.Y., Koenen H.J., Oosting M., Steinmeyer A., Zuegel U., Joosten I., Netea M.G., van der Ven A.J. Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine 2011, 55:294-300.
31. Malm J., Sorensen O., Persson T., Frohm-Nilsson M., Johansson B., Bjartell A., Lilja H., Ståhle-Bäckdahl M., Borregaard N., Egesten A. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect. Immun. 2000, 68:4297-4302.
32. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004, 75:39-48.
33. Bachrach G., Altman H., Kolenbrander P.E., Chalmers N.I., Gabai-Gutner M., Mor A., Friedman M., Steinberg D. Resistance of porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob. Agents Chemother. 2008, 52:638-642.
34. Kelley W.L., Lew D.P., Renzoni A. Antimicrobial peptide exposure and reduced susceptibility to daptomycin: insights Into a complex genetic puzzle. J. Infect. Dis. 2012, 206:1153-1156.
35. Peschel A., Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4:529-536.
36. Ganeshnarayan K., Velliyagounder K., Furgang D., Fine D.H. Human salivary cystatin SA exhibits antimicrobial effect against Aggregatibacter actinomycetemcomitans. J. Periodontal Res. 2012, 47:661-673.